India’s tally of Covid infections rose by 15,940 in a day to reach 4,33,78,234 while the active caseload increased to 91,779, according to the Union Health Ministry data updated on Saturday.
The death toll climbed to 5,24,974 with 20 more fatalities, the data updated at 8 am stated. Active cases rose by 3,495 in a day and now comprise 0.21 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.58 per cent, the health ministry said.
Active cases rose by 3,495 in a day and now comprise 0.21 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.58 per cent, the health ministry said.
The daily positivity rate was recorded at 4.39 per cent while the weekly positivity rate was 3.30 per cent, according to the health ministry. The number of people who have recuperated from the disease surged to 4,27,61,481, while the case fatality rate was 1.21 per cent.
According to the ministry, 196.94 crore doses of Covid vaccine have been administered in the country so far. India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, and 80 lakh on October 29, 90 lakh on November 20, surpassing the one-crore mark on December 19.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The country crossed the grim milestone of two crore on May 4, three crore on June 23 and four crore on January 25 this year. Of the 20 more fatalities reported, 11 are from Kerala, three from Maharashtra, two from West Bengal and one each from Bihar, Delhi, Punjab and Rajasthan.
A total of 5,24,974 deaths have been reported so far in the country, including 1,47,896 from Maharashtra, 69,935 from Kerala, and 40,114 from Karnataka, 38,026 from Tamil Nadu, 26,243 from Delhi, 23,532 from Uttar Pradesh and 21,214 from West Bengal.
Of the 20 more fatalities reported, 11 are from Kerala, three from Maharashtra, two from West Bengal and one each from Bihar, Delhi, Punjab and Rajasthan.